The acquisition transforms Ingredion into a global specialty ingredient leader with enhanced scale and diversification. Monitor regulatory approvals (antitrust) and shareholder votes; the 59% premium and irrevocable undertaking from a 16.8% holder suggest high closing probability. Leverage at 3.0x is manageable for an investment-grade credit, and synergy targets are credible. Expect positive stock reaction on strategic rationale and EPS accretion.
Price Chart
Executive Summary
Ingredion announced a recommended all-cash offer to acquire Tate & Lyle PLC for approximately £3.7B ($5.0B), representing a 59% premium to Tate & Lyle's closing price on May 13, 2026. The deal combines complementary specialty ingredient portfolios in texturants, sugar reduction, and fortification, with expected run-rate cost synergies of ~$130M by 2030. The acquisition is expected to close in the second half of 2027, subject to shareholder and regulatory approvals.
Key Financial Metrics
Key Facts
- All-cash offer for Tate & Lyle at 595 pence per share, a ~59% premium to May 13, 2026 closing price
- Total enterprise value of approximately £3.7B ($5.0B)
- Expected run-rate net cost synergies of ~$130M, fully realized by end of 2030
- One-time integration costs of ~$175M through 2030
- Expected to be adjusted EPS accretive in first year post-close
- Pro forma net leverage at completion ~3.0x, targeting ~2.5x within 18 months
- Ingredion's 2025 annual net sales ~$7.2B; Tate & Lyle FY2026 revenue ~£2.0B
- Huber Equity Corporation (16.8% of Tate & Lyle shares) has irrevocably agreed to vote in favor
- Completion expected in second half of 2027
Financial Impact
£3.7B ($5.0B) enterprise value; $130M annual cost synergies; $175M one-time integration costs
Risk Factors
- Regulatory antitrust conditions may delay or block the deal
- Integration risks and failure to achieve $130M cost synergies
- Higher-than-expected leverage or debt financing costs
- Currency risk from GBP/USD exchange rate fluctuations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3307802 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $101.74 $104.74 | ▲ +2.95% | ▼ −2.07% | $95.33 (−6.30%) |
Jun 30, 2026 13w ago | Press Release | $94.71 $101.45 | ▲ +7.12% | ▲ +8.14% | $95.33 (+0.65%) |
Jun 30, 2026 13w ago | 8-K | $94.71 $101.45 | ▲ +7.12% | ▲ +8.14% | $95.33 (+0.65%) |
Jun 25, 2026 14w ago | 8-K | $97.50 $100.25 | ▲ +2.82% | ▲ +1.56% | $95.33 (−2.23%) |
Jun 9, 2026 16w ago | 8-K | $102.54 $97.49 | ▼ −4.92% | ▼ −8.55% | $95.33 (−7.03%) |
Jun 8, 2026 16w ago | Press Release | $99.66 $99.29 | ▼ −0.37% | ▼ −2.00% | $95.33 (−4.34%) |
Jun 2, 2026 17w ago | Press Release | $101.12 $95.62 | ▼ −5.44% | ▼ −3.87% | $95.33 (−5.73%) |
May 28, 2026 18w ago | Press Release | $103.21 $97.50 | ▼ −5.53% | ▼ −2.39% | $95.33 (−7.63%) |
May 20, 2026 19w ago | Press Release | $102.15 $97.91 | ▼ −4.15% | ▼ −4.48% | $95.33 (−6.68%) |
May 14, 2026 20w ago | 8-K | $102.25 $101.59 | ▼ −0.65% | ▲ +0.21% | $95.33 (−6.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access